Hi-Bio

Biogen’s HI-Bio Buy Is Latest Biopharma Spending Spree in Projected $257B Immunology Market
BioSpace
Wed, 06/12/24 - 11:09 am
Biogen
Hi-Bio
M&A
HI-Bio's expectations elevated after pair of phase 2 readouts bolster autoimmune ambitions
Fierce Biotech
Tue, 04/11/23 - 11:36 am
Hi-Bio
Human Immunology Bioscience
kidney disease
felzartamab